Versor Investments LP Horizon Therapeutics Public LTD CO Transaction History

Versor Investments LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$98.98 - $115.74 $4.95 Million - $5.78 Million	-49,981 Reduced 39.57%	76,318 $8.83 Million
Q2 2023 Aug 07, 2023	SELL	$96.34 - $112.38 $6.83 Million - $7.97 Million	-70,928 Reduced 35.96%	126,299 $13 Million
Q1 2023 May 05, 2023	SELL	$107.32 - $113.5 $10.6 Million - $11.2 Million	-98,805 Reduced 33.38%	197,227 $21.5 Million
Q4 2022 Jan 30, 2023	BUY	$62.39 - $113.8 $18.5 Million - $33.7 Million	296,032 New	296,032 $33.7 Million
Q4 2020 Feb 10, 2021	SELL	$67.0 - $84.39 $670,000 - $843,900	-10,000 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$55.23 - $79.93 $552,300 - $799,300	10,000 New	10,000 $777,000
Q2 2020 Jul 30, 2020	SELL	$30.2 - $56.98 $492,260 - $928,774	-16,300 Closed	0 $0
Q1 2020 Apr 28, 2020	BUY	$24.87 - $38.56 $405,381 - $628,528	16,300 New	16,300 $483,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

Stay updated on Versor Investments LP with notifications on news.